EPO and Cognitive impairment: In summary, the present study suggests a novel pathogenic link between SZ and cognitive impairments, where EPO deficiency upregulates GADD45b triggering p38 MAPK activation and apoptosis in SZ, thus leading to the synaptic damage and cognitive impairments (Figure7).